 | VR MED (VRMD)ICO VR MED – VR solution in MedTech. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
OpenWhat is VR MED
- Vision Field Analyzer: The VR MED headset provides vision field analysis to allow physicians to diagnosis early-stage glaucoma. Now the equipment is undergoing testing at the Institute of Eye Diseases at the Russian Academy of Sciences.
- Portability: The VR MED headset is mobile. To use it, the clinician needs only the headset itself, and the notebook that it will be plugged into. Its weight (0.4 kg, about one pound) and compact dimensions add to its ease of transport. It can be used in mobile medical units, small stationary clinics and with telemedicine set-ups.
- Ergonomic Design: VR MED is integrated into a headset whic provides an accuracy in eye-tracking. This gives the headset versatility for use in various medical settings.
DetailsPre-sales: Mar 15, 2018 - Apr 15, 2018Token supply: 24000000 | Token infoTicker: VRMDType: Utility-token Token standard: ERC-20 Token price in USD: 1 Token = 0.250000 USD Accepted currencies: USD, BTC, ETH Bonus program: Discount for 1 VRMD at the stage of pre-sale for early investors will be 25%. Token distribution: 66% - Crowdsale 13% - Team, bounty, marketing 21% - ICO 2.0 reserve Funds allocation: 20% - Headset refinement (including functional expansion) 20% - IT costs (SW, DB developers), headset technical developers (improvement of the eye-tracker) 18% - Project marketing (opinion leaders, conferences, publications in specialized media) 42% - Certification in the countries of EurAsEC, EU, India, China |
VR MED Roadmap
Start of the development of the VR headset and programming suitable for medical use.
Patent granted in Russia.
Start of process to receive international patents.
Creation of pilot model of equipment and software for screening for early detection of glaucoma and other conditions with peripheral vision defects.
Successful experimental outcomes in the Institute of Eye Diseases at the Russia Academy of Sciences.
Participation at international presentations in Lisbon and Bahrain. Introduction of the device.
Successful approval process for the device and software at the FH Aachen University of Applied Sciences.
Development of the Alpha version of the device, with the capability of providing solutions in ophthalmology (measurement of peripheral vision, diagnosis of glaucoma markers).
Development of the device final version (technical and usage fine-tuning), construct improvements.
Standard ISO 12866-2011. Industrial design development.
Certification of software Perimeter: Creation of a universal design for diagnosis of a range of visual functions (through early diagnosis of glaucoma and other peripheral vision field defects).
Entrance to the world market: Undergo approval process in India and China clinics; obtain international ISO certification.
Upload of users data to the platform. Distribution of the device in the European Union, Russia and Asia;
Launch of decentralized platform;
The 100% functional Perimeter becomes the gold standard in ophthalmic diagnosis.
Widening of device functionality to include usage in neurology and rehabilitation.
Project team
Advisors
Social media
